Metabolism - Clinical and Experimental
Volume 44, Issue 7 , Pages 876-882 , July 1995

Insulin-resistant glucose metabolism in patients with microvascular angina—syndrome X

  • H. Vestergaard

      Affiliations

    • Corresponding Author InformationAddress reprint requests to H. Vestergaard, MD, Steno Diabetes Center, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark.
    • Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Denmark
    • Department of Medicine B, Division of Cardiology, National University Hospital, Copenhagen, Denmark
    • ,
  • P. Skøtt

      Affiliations

    • Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Denmark
    • Department of Medicine B, Division of Cardiology, National University Hospital, Copenhagen, Denmark
    • ,
  • R. Steffensen

      Affiliations

    • Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Denmark
    • Department of Medicine B, Division of Cardiology, National University Hospital, Copenhagen, Denmark
    • ,
  • H. Wroblewski

      Affiliations

    • Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Denmark
    • Department of Medicine B, Division of Cardiology, National University Hospital, Copenhagen, Denmark
    • ,
  • O. Pedersen

      Affiliations

    • Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Denmark
    • Department of Medicine B, Division of Cardiology, National University Hospital, Copenhagen, Denmark
    • ,
  • J. Kastrup

      Affiliations

    • Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Denmark
    • Department of Medicine B, Division of Cardiology, National University Hospital, Copenhagen, Denmark

Received 30 March 1994 ,Accepted 12 October 1994.

References 

  1. Cannon RO, Camici PG, Epstein SE. Pathophysiological dilemma of syndrome X. Circulation. 1992;85:883–892
  2. Cannon RO. Microvascular angina. In: Cardiovascular investigations regarding pathophysiology and management. Med Clin North Am. 75:1991;p. 1097–1118
  3. Cannon RO, Schenke WH, Leon MB, et al.  Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction. Circulation. 1987;1:163–174
  4. Sax FL, Cannon RO, Hanson C, et al.  Impaired forearm vasodilator reserve in patients with microvascular angina. N Engl J Med. 1987;317:1366–1370
  5. Cannon RO. The coronary microcirculation in heart disease: Hypertrophic cardiomyopathy, hypertension, and microvascular angina. Coronary Artery Dis. 1992;3:555–563
  6. Dean JD, Jones CJH, Hutchison SJ, et al.  Hyperinulinaemia and microvascular angina (“syndrome X”). Lancet. 1991;337:456–457
  7. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol. 1979;6:E214–E223
  8. Steele R. Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci. 1959;82:420–430
  9. Cobelli C, Mari A, Ferrannini E. Non-steady state: Error analysis of Steele's model and development for glucose kinetics. Am J Physiol. 1987;252:E679–E689
  10. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol. 1983;55:628–634
  11. Bak JF, Pedersen O. Exercise-enhanced activation of glycogen synthase in human skeletal muscle. Am J Physiol. 1990;258:E957–E963
  12. Vestergaard H, Lund S, Larsen FS, et al.  Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin resistant patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1993;91:2342–2350
  13. Andersen I, Hannibal S. Analytical and economical optimization of a glucose method with immobilized enzymes. J Autom Chem. 1983;5:188–192
  14. Andersen L, Dinesen B, Jørgensen PN, et al.  Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem. 1993;39:578–582
  15. Heding LG. Radioimmunological determination of human C-peptide in serum. Diabetologia. 1975;11:541–548
  16. Hother-Nielsen O, Schmitz O, Bak JF, et al.  Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with type I (insulin-dependent) diabetes. Diabetologia. 1987;30:834–840
  17. Itaya K, Michio U. Colorimetric determination of free fatty acids in biological fluids. J Lipid Res. 1965;6:16–20
  18. Gray DS, Bray GA, Gemayel N, et al.  Effect of obesity on bioelectrical impedance. Am J Clin Nutr. 1989;50:255–260
  19. Kaski JC, McKenna J. Angina pectoris with normal coronary arteriograms. In: Overview. Coronary Artery Dis. 3:1992;p. 547–554
  20. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607
  21. Bøtker HE, Møller N, Ovesen P, et al.  Insulin resistance in microvascular angina (syndrome X). Lancet. 1993;342:136–140
  22. Fuh MM-T, Jeng C-Y, Young MM-S, et al.  Insulin resistance, glucose intolerance, and hyperinsulinemia in patients with microvascular angina. Metabolism. 1993;42:1090–1092
  23. DeFronzo RA, Bonadonna R, Ferrannini E. Pathogenesis of NIDDM. In: A balanced overview. Diabetes Care. 15:1992;p. 318–368
  24. Stalmans W, Bollen M, Mvumbi L. Control of glycogen synthesis in health and disease. Diabetes Metab Rev. 1987;3:127–161
  25. Cohen P. Muscle glycogen synthase. In:  Boyer PD,  Krebs EG editor. The Enzymes. vol 3:Orlando, FL: Harcourt Brace Jovanovich; 1986;p. 461–497
  26. Roach PJ. Control of glycogen synthase by hierarchal protein phosphorylation. FASEB J. 1990;4:2961–2968
  27. Okubo M, Bogardus C, Lillioja S, et al.  Glucose-6-phosphate stimulation of human muscle glycogen synthase phosphatase. Metabolism. 1988;37:1171–1176
  28. Dent P, Lavoinne A, Nakielny S, et al.  The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature. 1990;348:302–308
  29. Andréasson K, Galuska D, Thorne A, et al.  Decreased insulin-stimulated 3-O-methylglucose transport in in vitro incubated muscle strips from type II diabetic subjects. Acta Physiol Scand. 1991;142:255–260
  30. Dohm GL, Tapscott EB, Pories WJ, et al.  An in vitro human muscle preparation suitable for metabolic studies. In: Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J Clin Invest. 82:1988;p. 486–494
  31. Fink RI, Wallace P, Brechtel G, et al.  Evidence that glucose transport is rate-limiting for in vivo glucose uptake. Metabolism. 1992;41:897–902
  32. Yki-Järvinen H, Sahlin K, Ren JM, et al.  Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients. Diabetes. 1990;39:157–167
  33. Rothman DL, Shulman RG, Shulman GI. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. In: Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest. 89:1992;p. 1069–1075
  34. Mandarino LJ, Consoli A, Kelley DE, et al.  Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1990;71:1544–1551
  35. Vaag A, Damsbo P, Hother-Nielsen O, et al.  Hyperglycemia compensates for the defect in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35:80–88
  36. Hartling O, Svendsen TL, Nielsen PE, et al.  The distensibility of the resistance vessels of skeletal muscle in hypertensive patients. Acta Physiol Scand. 1978;103:430–436
  37. Kastrup J. The diabetic arteriole: The impact of diabetic microangiopathy on microcirculatory control. Dan Med Bull. 1988;35:334–345
  38. DeFronzo RA, Ferrannini E. Insulin resistance. In: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care. 14:1991;p. 173–194

☆ Supported by grants from the Danish Diabetes Association, Frimodt-Heiniken Foundation, Poul and Erna Sehsted Hansen Foundation, and Director Jacob Madsen and Olga Madsen Foundation, Denmark.

PII: 0026-0495(95)90240-6

Metabolism - Clinical and Experimental
Volume 44, Issue 7 , Pages 876-882 , July 1995

Article Tools